Laura R. Bohrer

1.3k total citations
24 papers, 985 citations indexed

About

Laura R. Bohrer is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Laura R. Bohrer has authored 24 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Laura R. Bohrer's work include Retinal Development and Disorders (12 papers), Pluripotent Stem Cells Research (6 papers) and CRISPR and Genetic Engineering (6 papers). Laura R. Bohrer is often cited by papers focused on Retinal Development and Disorders (12 papers), Pluripotent Stem Cells Research (6 papers) and CRISPR and Genetic Engineering (6 papers). Laura R. Bohrer collaborates with scholars based in United States, Canada and Germany. Laura R. Bohrer's co-authors include Haojie Huang, Kathryn L. Schwertfeger, Yunqian Pan, Daiwen Chen, Budd A. Tucker, Robert F. Mullins, Anindya Bagchi, Lu Gan, Xianzheng Zhou and Jeffrey A. Simon and has published in prestigious journals such as Journal of Clinical Investigation, Nature Cell Biology and Cancer Research.

In The Last Decade

Laura R. Bohrer

23 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura R. Bohrer United States 15 684 256 194 187 113 24 985
Dantong Sun China 18 739 1.1× 259 1.0× 459 2.4× 141 0.8× 92 0.8× 43 1.2k
Barbara Tanno Italy 19 737 1.1× 77 0.3× 423 2.2× 268 1.4× 47 0.4× 45 1.1k
Shannon Matheny United States 11 451 0.7× 202 0.8× 306 1.6× 389 2.1× 144 1.3× 36 1.0k
Fahao Zhang United States 16 491 0.7× 196 0.8× 310 1.6× 124 0.7× 25 0.2× 25 844
Markus Bredel United States 15 565 0.8× 105 0.4× 251 1.3× 199 1.1× 27 0.2× 28 914
Demirkan Gursel United States 19 491 0.7× 104 0.4× 270 1.4× 284 1.5× 28 0.2× 32 970
Barbara Ikejiri United States 19 376 0.5× 77 0.3× 233 1.2× 233 1.2× 31 0.3× 28 901
R M de Waal Netherlands 10 464 0.7× 88 0.3× 205 1.1× 144 0.8× 58 0.5× 12 821
Christine Neuhaus Germany 14 733 1.1× 166 0.6× 42 0.2× 169 0.9× 90 0.8× 26 899
Hiroko Ohgaki France 11 552 0.8× 154 0.6× 324 1.7× 306 1.6× 41 0.4× 12 971

Countries citing papers authored by Laura R. Bohrer

Since Specialization
Citations

This map shows the geographic impact of Laura R. Bohrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura R. Bohrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura R. Bohrer more than expected).

Fields of papers citing papers by Laura R. Bohrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura R. Bohrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura R. Bohrer. The network helps show where Laura R. Bohrer may publish in the future.

Co-authorship network of co-authors of Laura R. Bohrer

This figure shows the co-authorship network connecting the top 25 collaborators of Laura R. Bohrer. A scholar is included among the top collaborators of Laura R. Bohrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura R. Bohrer. Laura R. Bohrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bohrer, Laura R., Nathaniel K. Mullin, A. Berthold, et al.. (2025). Device-free isolation of photoreceptor cells from patient iPSC-derived retinal organoids. JCI Insight. 10(14). 2 indexed citations
2.
Bohrer, Laura R., Luke A. Wiley, Louisa M. Affatigato, et al.. (2025). Production of clinical grade patient iPSC-derived 3D retinal organoids containing transplantable photoreceptor cells. Stem Cell Research & Therapy. 16(1). 641–641. 1 indexed citations
3.
4.
Mullin, Nathaniel K., Laura R. Bohrer, Andrew P. Voigt, et al.. (2024). NR2E3 loss disrupts photoreceptor cell maturation and fate in human organoid models of retinal development. Journal of Clinical Investigation. 134(11). 8 indexed citations
5.
Powell, Kimerly, Laura R. Bohrer, Kristin R. Anfinson, et al.. (2023). Automated human induced pluripotent stem cell colony segmentation for use in cell culture automation applications. SLAS TECHNOLOGY. 28(6). 416–422. 5 indexed citations
6.
Bohrer, Laura R., et al.. (2023). CGMP Compliant Microfluidic Transfection of Induced Pluripotent Stem Cells for CRISPR-Mediated Genome Editing. Stem Cells. 41(11). 1037–1046. 5 indexed citations
7.
Bohrer, Laura R., Nathaniel K. Mullin, Andrew P. Voigt, et al.. (2023). Automating iPSC generation to enable autologous photoreceptor cell replacement therapy. Journal of Translational Medicine. 21(1). 161–161. 19 indexed citations
8.
Han, Ian C., Laura R. Bohrer, Katherine N. Gibson‐Corley, et al.. (2022). Biocompatibility of Human Induced Pluripotent Stem Cell–Derived Retinal Progenitor Cell Grafts in Immunocompromised Rats. Cell Transplantation. 31. 4221162307–4221162307. 16 indexed citations
9.
Mullin, Nathaniel K., Andrew P. Voigt, Laura R. Bohrer, et al.. (2020). Patient derived stem cells for discovery and validation of novel pathogenic variants in inherited retinal disease. Progress in Retinal and Eye Research. 83. 100918–100918. 18 indexed citations
10.
Bohrer, Laura R., Luke A. Wiley, Erin R. Burnight, et al.. (2019). Correction of NR2E3 Associated Enhanced S-cone Syndrome Patient-specific iPSCs using CRISPR-Cas9. Genes. 10(4). 278–278. 31 indexed citations
11.
Burnight, Erin R., Joseph C. Giacalone, Laura R. Bohrer, et al.. (2018). CRISPR-Cas9 genome engineering: Treating inherited retinal degeneration. Progress in Retinal and Eye Research. 65. 28–49. 60 indexed citations
12.
Burnight, Erin R., Laura R. Bohrer, Joseph C. Giacalone, et al.. (2018). CRISPR-Cas9-Mediated Correction of the 1.02 kb Common Deletion in CLN3 in Induced Pluripotent Stem Cells from Patients with Batten Disease. The CRISPR Journal. 1(1). 75–87. 14 indexed citations
13.
He, Yuting, Yanhong Zhao, Liguo Wang, et al.. (2017). LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation. Oncogene. 37(4). 534–543. 41 indexed citations
14.
Farooqui, Mariya, Laura R. Bohrer, Nicholas J. Brady, et al.. (2015). Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival. Molecular Cancer. 14(1). 138–138. 28 indexed citations
15.
Zhong, Jian, Liya Ding, Laura R. Bohrer, et al.. (2014). p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis. Cancer Research. 74(6). 1870–1880. 80 indexed citations
16.
Bohrer, Laura R., Pavlina Chuntova, Thomas C. Beadnell, et al.. (2013). Activation of the FGFR–STAT3 Pathway in Breast Cancer Cells Induces a Hyaluronan-Rich Microenvironment That Licenses Tumor Formation. Cancer Research. 74(1). 374–386. 59 indexed citations
17.
Bohrer, Laura R., Ping Liu, Jian Zhong, et al.. (2013). FOXO1 binds to the TAU5 motif and inhibits constitutively active androgen receptor splice variants. The Prostate. 73(10). 1017–1027. 39 indexed citations
18.
Bohrer, Laura R. & Kathryn L. Schwertfeger. (2012). Macrophages Promote Fibroblast Growth Factor Receptor-Driven Tumor Cell Migration and Invasion in a Cxcr2-Dependent Manner. Molecular Cancer Research. 10(10). 1294–1305. 66 indexed citations
19.
Chen, Daiwen, Laura R. Bohrer, Yunqian Pan, et al.. (2010). Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nature Cell Biology. 12(11). 1108–1114. 202 indexed citations
20.
Gan, Lu, Yuwei Wang, Akira Watahiki, et al.. (2009). Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer. Cancer Research. 69(21). 8386–8394. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dantong Sun Breakdown of academic impact, for papers by Barbara Tanno Breakdown of academic impact, for papers by Shannon Matheny Breakdown of academic impact, for papers by Fahao Zhang Breakdown of academic impact, for papers by Markus Bredel Breakdown of academic impact, for papers by Demirkan Gursel Breakdown of academic impact, for papers by Barbara Ikejiri Breakdown of academic impact, for papers by R M de Waal Breakdown of academic impact, for papers by Christine Neuhaus Breakdown of academic impact, for papers by Hiroko Ohgaki
Rankless by CCL
2026